Brain stimulation · 2025
Thalamocortical white matter connectivity and the entorhinal cortex as neural correlates of electroconvulsive therapy response in patients with schizophrenia spectrum disorder.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Minah, Choe Eugenie, Park Hyungyou, Lho Silvia Kyungjin, Moon Sun-Young, Oh Sanghoon, Kwon Jun Soo
Аннотация
BACKGROUND: Electroconvulsive therapy (ECT) is an effective treatment for patients with treatment-resistant schizophrenia spectrum disorder (SSD); however, the underlying mechanisms of ECT remain unclear, and region-specific neuromodulation targets are not well defined. Abnormally reduced thalamo-prefrontal cortex (PFC) and increased thalamo-parietal cortex (PC) connectivity have been linked to schizophrenia pathophysiology. In this study, thalamocortical white matter (WM) connectivity was examined as a potential biomarker of ECT response, and the brain regions that mediate ECT-induced changes in SSD patients were explored.
METHODS: Twenty-six SSD patients and 28 age- and sex-matched healthy controls (HCs) underwent diffusion-weighted magnetic resonance imaging to assess thalamocortical WM connectivity. SSD patients were scanned twice, before (T1) and after (T2) ECT, over 1-2 months. Associations between changes in thalamocortical WM connectivity and symptom improvement were analyzed. Mediation analysis using graph theoretical analysis of structural connectomes was performed to identify modulating regions associated with WM connectivity changes.
RESULTS: At T1, SSD patients exhibited lower thalamo-lateral PFC and greater thalamo-PC WM connectivity than HCs did. At T2, the group-level difference in thalamo-PC WM connectivity disappeared. In SSD patients, thalamo-PC WM connectivity significantly decreased between T1 and T2, which was associated with symptom improvement. Mediation analysis revealed that the degree centrality of the right entorhinal cortex significantly mediated ECT-induced changes in thalamo-PC WM connectivity.
CONCLUSION: These findings suggest that a reduction in increased thalamo-PC WM connectivity may be a biomarker for ECT response in SSD patients. Furthermore, the right entorhinal cortex may be a neuromodulation target for treatment-resistant SSD.
METHODS: Twenty-six SSD patients and 28 age- and sex-matched healthy controls (HCs) underwent diffusion-weighted magnetic resonance imaging to assess thalamocortical WM connectivity. SSD patients were scanned twice, before (T1) and after (T2) ECT, over 1-2 months. Associations between changes in thalamocortical WM connectivity and symptom improvement were analyzed. Mediation analysis using graph theoretical analysis of structural connectomes was performed to identify modulating regions associated with WM connectivity changes.
RESULTS: At T1, SSD patients exhibited lower thalamo-lateral PFC and greater thalamo-PC WM connectivity than HCs did. At T2, the group-level difference in thalamo-PC WM connectivity disappeared. In SSD patients, thalamo-PC WM connectivity significantly decreased between T1 and T2, which was associated with symptom improvement. Mediation analysis revealed that the degree centrality of the right entorhinal cortex significantly mediated ECT-induced changes in thalamo-PC WM connectivity.
CONCLUSION: These findings suggest that a reduction in increased thalamo-PC WM connectivity may be a biomarker for ECT response in SSD patients. Furthermore, the right entorhinal cortex may be a neuromodulation target for treatment-resistant SSD.